Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study

BACKGROUND: To investigate the effectiveness and safety of 3 mg drospirenone and 20 μg ethinyl estradiol tablet (3 mg DRSP/20 μg EE) in the treatment of polycystic ovary syndrome (PCOS). METHODS: This single center, prospective observational study was conducted in 140 patients with PCOS. They were p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Zhang, Ruiqin, Zeng, Jing, Ke, Hu, Peng, Xiuhong, Huang, Liying, Zhang, Hongmei, Chen, Zhijing, Li, Tian Tian, Tan, Qiuxiao, Yang, Ying, Li, Xiaofang, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047377/
https://www.ncbi.nlm.nih.gov/pubmed/32106860
http://dx.doi.org/10.1186/s12905-020-00905-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047377/
https://www.ncbi.nlm.nih.gov/pubmed/32106860
http://dx.doi.org/10.1186/s12905-020-00905-x

Ejemplares similares